The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

Advisers, some employees and some board members are scoring payouts ranging from $75,000 to $53 million.

A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

Study met primary and secondary endpointsParidiprubart demonstrated a relative reduction in the risk of death of 25%Treatment provided patients ...

Aurion Biotech has released positive 12-month results from its phase 1/2 CLARA trial evaluating the safety, efficacy, and ...

The Arlington biotech has been forced to lay off its remaining staff, including its CEO.

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.1% ...

The future will belong to leaders who balance bold ideas with deep foresight and design solutions that serve humanity, not ...

The biotech sector has long offered investors high-risk, high-reward stocks. While large players are making headlines, the ...

In today’s fast-paced and competitive biotechnology landscape, control and speed define success for companies and core labs ...

Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...